Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T44057
(Former ID: TTDI03034)
|
|||||
Target Name |
Aquaporin-1 (AQP1)
|
|||||
Synonyms |
Water channel protein for red blood cells and kidney proximal tubule; Urine water channel; CHIP28; Aquaporin-CHIP; AQP-1
Click to Show/Hide
|
|||||
Gene Name |
AQP1
|
|||||
Target Type |
Clinical trial target
|
[1] | ||||
Disease | [+] 1 Target-related Diseases | + | ||||
1 | Lips/oral mucosa miscellaneous disorder [ICD-11: DA02] | |||||
Function |
Forms a water-specific channel that provides the plasma membranes of red cells and kidney proximal tubules with high permeability to water, thereby permitting water to move in the direction of an osmotic gradient.
Click to Show/Hide
|
|||||
BioChemical Class |
Major intrinsic protein
|
|||||
UniProt ID | ||||||
Sequence |
MASEFKKKLFWRAVVAEFLATTLFVFISIGSALGFKYPVGNNQTAVQDNVKVSLAFGLSI
ATLAQSVGHISGAHLNPAVTLGLLLSCQISIFRALMYIIAQCVGAIVATAILSGITSSLT GNSLGRNDLADGVNSGQGLGIEIIGTLQLVLCVLATTDRRRRDLGGSAPLAIGLSVALGH LLAIDYTGCGINPARSFGSAVITHNFSNHWIFWVGPFIGGALAVLIYDFILAPRSSDLTD RVKVWTSGQVEEYDLDADDINSRVEMKPK Click to Show/Hide
|
|||||
3D Structure | Click to Show 3D Structure of This Target | PDB | ||||
HIT2.0 ID | T75NEV |
Drugs and Modes of Action | Top | |||||
---|---|---|---|---|---|---|
Clinical Trial Drug(s) | [+] 1 Clinical Trial Drugs | + | ||||
1 | AAV-AQP1 | Drug Info | Phase 1/2 | Xerostomia | [2] | |
Mode of Action | [+] 1 Modes of Action | + | ||||
Inhibitor | [+] 1 Inhibitor drugs | + | ||||
1 | [14C]TEA | Drug Info | [1] |
Cell-based Target Expression Variations | Top | |||||
---|---|---|---|---|---|---|
Cell-based Target Expression Variations |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
Ligand Name: Cholesterol | Ligand Info | |||||
Structure Description | Erythrocyte ankyrin-1 complex class 2 local refinement of AQP1 (C4 symmetry applied) | PDB:7UZE | ||||
Method | Electron microscopy | Resolution | 2.40 Å | Mutation | No | [3] |
PDB Sequence |
SEFKKKLFWR
12 AVVAEFLATT22 LFVFISIGSA32 LGFKYPVGNN42 QTAVQDNVKV52 SLAFGLSIAT 62 LAQSVGHISG72 AHLNPAVTLG82 LLLSQISIFR93 ALMYIIAQCV103 GAIVATAILS 113 GITSSLTGNS123 LGRNDLADGV133 NSGQGLGIEI143 IGTLQLVLCV153 LATTDRRRRD 163 LGGSAPLAIG173 LSVALGHLLA183 IDYTGCGINP193 ARSFGSAVIT203 HNFSNHWIFW 213 VGPFIGGALA223 VLIYDFILAP233 RSSDLTDRVK243 VWTSGQ
|
|||||
|
||||||
Click to View More Binding Site Information of This Target and Ligand Pair | ||||||
Ligand Name: S-Palmitoyl-L-cysteine | Ligand Info | |||||
Structure Description | Erythrocyte ankyrin-1 complex class 2 local refinement of AQP1 (C4 symmetry applied) | PDB:7UZE | ||||
Method | Electron microscopy | Resolution | 2.40 Å | Mutation | No | [3] |
PDB Sequence |
SEFKKKLFWR
12 AVVAEFLATT22 LFVFISIGSA32 LGFKYPVGNN42 QTAVQDNVKV52 SLAFGLSIAT 62 LAQSVGHISG72 AHLNPAVTLG82 LLLSQISIFR93 ALMYIIAQCV103 GAIVATAILS 113 GITSSLTGNS123 LGRNDLADGV133 NSGQGLGIEI143 IGTLQLVLCV153 LATTDRRRRD 163 LGGSAPLAIG173 LSVALGHLLA183 IDYTGCGINP193 ARSFGSAVIT203 HNFSNHWIFW 213 VGPFIGGALA223 VLIYDFILAP233 RSSDLTDRVK243 VWTSGQ
|
|||||
|
LEU81
2.385
LEU83
3.248
LEU84
2.768
LEU85
2.335
SER86
1.329
GLN88
1.330
ILE89
3.399
VAL214
4.315
PHE217
2.395
ILE218
3.148
ALA221
2.298
|
|||||
Click to View More Binding Site Information of This Target and Ligand Pair | ||||||
Click to View More Binding Site Information of This Target with Different Ligands |
Different Human System Profiles of Target | Top |
---|---|
Human Similarity Proteins
of target is determined by comparing the sequence similarity of all human proteins with the target based on BLAST. The similarity proteins for a target are defined as the proteins with E-value < 0.005 and outside the protein families of the target.
A target that has fewer human similarity proteins outside its family is commonly regarded to possess a greater capacity to avoid undesired interactions and thus increase the possibility of finding successful drugs
(Brief Bioinform, 21: 649-662, 2020).
Human Pathway Affiliation
of target is determined by the life-essential pathways provided on KEGG database. The target-affiliated pathways were defined based on the following two criteria (a) the pathways of the studied target should be life-essential for both healthy individuals and patients, and (b) the studied target should occupy an upstream position in the pathways and therefore had the ability to regulate biological function.
Targets involved in a fewer pathways have greater likelihood to be successfully developed, while those associated with more human pathways increase the chance of undesirable interferences with other human processes
(Pharmacol Rev, 58: 259-279, 2006).
Biological Network Descriptors
of target is determined based on a human protein-protein interactions (PPI) network consisting of 9,309 proteins and 52,713 PPIs, which were with a high confidence score of ≥ 0.95 collected from STRING database.
The network properties of targets based on protein-protein interactions (PPIs) have been widely adopted for the assessment of target’s druggability. Proteins with high node degree tend to have a high impact on network function through multiple interactions, while proteins with high betweenness centrality are regarded to be central for communication in interaction networks and regulate the flow of signaling information
(Front Pharmacol, 9, 1245, 2018;
Curr Opin Struct Biol. 44:134-142, 2017).
Human Similarity Proteins
Human Pathway Affiliation
Biological Network Descriptors
|
There is no similarity protein (E value < 0.005) for this target
|
KEGG Pathway | Pathway ID | Affiliated Target | Pathway Map |
---|---|---|---|
Renin secretion | hsa04924 | Affiliated Target |
|
Class: Organismal Systems => Endocrine system | Pathway Hierarchy | ||
Proximal tubule bicarbonate reclamation | hsa04964 | Affiliated Target |
|
Class: Organismal Systems => Excretory system | Pathway Hierarchy | ||
Bile secretion | hsa04976 | Affiliated Target |
|
Class: Organismal Systems => Digestive system | Pathway Hierarchy |
Degree | 1 | Degree centrality | 1.07E-04 | Betweenness centrality | 0.00E+00 |
---|---|---|---|---|---|
Closeness centrality | 9.67E-02 | Radiality | 8.73E+00 | Clustering coefficient | 0.00E+00 |
Neighborhood connectivity | 5.00E+00 | Topological coefficient | 1.00E+00 | Eccentricity | 16 |
Download | Click to Download the Full PPI Network of This Target | ||||
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 688). | |||||
REF 2 | Clinical pipeline report, company report or official report of MeiraGTx. | |||||
REF 3 | Architecture of the human erythrocyte ankyrin-1 complex. Nat Struct Mol Biol. 2022 Jul;29(7):706-718. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.